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Both the U.S. Environmental Protection
Agency (EPA) and the World Health
Organization (WHO) are concerned with
potential health effects that might result from
increased exposure to ultraviolet radiation
(UVR) as a result ofdepletion ofstratospher-
ic ozone by anthropogenic chemicals such as
chlorofluorocarbons and halons. Major tar-
gets for UVR effects include the skin, eye,
and immune system. A thorough review of
effects ofUVR on these tissues was published
recently by WHO (1). In 1989, the EPA's
Health Effects Research Laboratory (HERL,
predecessor of NHEERL, the National
Health and Environmental Effects
Laboratory) convened an expert panel to
identify research needs to improve health risk
assessments with respect to UVR exposure.
At that time there were sufficient data to
make quantitative estimates of the risks of
skin cancer and cataract development associ-
ated with depletion of stratospheric ozone.
Studies also indicated that some immune
functions were compromised by exposure to
UVR and that this might influence the inci-
dence and severity of infectious diseases as
well as vaccine effectiveness. However, data
necessary to quantitate the risk to the
immune systemwere notavailable. As aresult
of recommendations from the expert panel,
HERL initiated a small, focused research
effort to improve this data base. The need to
accurately assess the risk ofUVR exposure to
the immune system is critical, since these
effects are expressed immediately, in contrast
to skin cancer and cataracts, which take years
to develop. In 1994, HERL and the UV
Monitoring and Assessment Program, an
industrial group, held a workshop that
focused on potential effects UVR- induced
immune suppression might have on infec-
tious disease in humans and conduded that
quantitative predictions were notpossible (2).
The subject ofthis report is a workshop
jointly sponsored by the EPA and WHO on
12-13 December 1995, "UVR-Induced
Immune Modulation: Potential Conse-
quences for Infectious, Allergic, and
Autoimmune Disease," in Chapel Hill, NC.
The aims ofthe workshop were 1) to review
currendy available studies relevant to assess-
ing risks associated with UVR effects on the
immune system, 2) to identify needs for fur-
ther research to improve the risk assessment
process, and 3) to recommend and prioritize
specific research projects for which WHO
should actively seek funding. Two of the
most problematic areas for risk assessment
are extrapolating from immune function
data obtained in laboratory rodents to
humans, and extrapolating from effects on
human immune functions to potential
effects on infectious diseases and/or vaccine
effectiveness. These issues were addressed in
sessions one and two, respectively. Session
three dealt with the possibility that UVR
immune modulation may impact allergic
and autoimmune disease aswell.
Session 1: Quantitative comparisons
between human andmousestudies:applica-
tions to the development ofrisk assessment
models. Dr. Noonan reviewed experimental
evidence for dose and wavelength-depen-
dent UVR-induced modulation of contact
hypersensitivity (CH) and delayed-type
hypersensitivity (DTH) in mice. Sup-
pression ofthese immune responses appears
to play a critical role in the growth ofskin
cancers and enhances the progression ofcer-
tain infections in mice. Dose-response data
from astudy (3) of18 strains ofinbred mice
demonstrated three phenotypes for suppres-
sion of CH (Table 1). The total dose
required for immune suppression is much
less than that required for skin cancer
induction and, unlike cancer induction, is
independent ofdose-rate and dose fraction-
ation. Dr. Assafthen presented studies done
by Cooper et al. (in collaboration with the
EPA) showing dose-response curves for
UVR-induced suppression of CH in
humans [KD. Cooper, personal communi-
cation; (4)]. Subjects (ranging from light
skinned to heavily pigmented) were
grouped according to UVR sensitivity based
on minimal erythemal dose, and doses of
UVR causing 50% immunosuppression
were determined for each skin type (Table
1). These doses could easily be achieved at
midday in temperate latitudes under sum-
mer sun and were less than that required to
achieve 50% suppression in the most sensi-
tive mice in Noonan's studies. Hence, the
responses of mice and humans to UVR-
induced suppression of CH are quantita-
tively similar (Table 1). Dr. Selgrade
described a parallelogram model (Fig. 1)
that has been used to make comparisons
between effects in laboratory rodents and
humans, and between deficits in immune
function and increased susceptibility to dis-
ease (5). In such models, dose-response data
from Drs. Noonan and Assafwould corre-
spond to the upper corners of the parallelo-
gram. Dose-response data on host resistance
to infection in mice and the potential for
assessing vaccine effectiveness in humans
presented in session two would correspond
to the lower corners. Quantitative compar-
isons could then be made between the cor-
ners ofthe parallelogram, which would indi-
cate how well CHS predicts effects on
response to infectious disease and how well
mouse datapredicts human effects.
Session 2: Potential impact ofUVR on
infectious disease and vaccine effectiveness.
Dr. Jeevan reviewed studies in which UVR
exposure increased the incidence and/or
severity ofinfection in mice challenged with
viral, parasitic, fungal, and bacterial agents.
She presented data with Mycobacterium bovis
BCG (the vaccine strain for tuberculosis)
and M. lepraemurium (a mouse leprosy
model). The UVR dose required for 50%
suppression of the DTH response to these
two agents (Table 1) resulted in approxi-
mately a threefold increase in the number of
BCG bacteria in spleen and lymph nodes of
infected mice (6). Dr. van Loveren described
similar studies in rats in which there was a
strong relationship between suppression of
the in vitro lymphoproliferative response to
bacterial antigen following in vivo UVR
exposure and increased susceptibility to chal-
lenge with bacteria. Also, he reported a 3.8-
fold difference in the dose required to sup-
press the skin-mixed lymphocyte response by
50% in humans and rats and indicated that
his data could be applied in a parallelogram
model to predict effects on resistance to bac-
terial infection in humans. (Table 1) (7). Dr.
Ward described three opportunities for field
studies to assess effects ofUVR exposure on
vaccine effectiveness in humans. First, vacci-
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nation with BCG is about 50% effective
against tuberculosis and is given to most
children in developing nations shordy after
birth. In some ofthese same nations, hyper-
bilirubinemia in newborns is treated by
graded solar exposure (containing UVR),
usually before BCG vaccination. Children
without hyperbilirubinemia are generally
protected from the sun. Hence, comparison
of subsequent responses to BCG in these
two populations would provide an indica-
tion of the effect of UVR on vaccine-
induced immunity. Second, a study of the
influence of season on cellular responses to
measles vaccine presents another opportuni-
tywhen conducted in an area with dramatic
seasonal differences in climatic conditions
(e.g., Lima, Peru). Third, a comparison of
hepatitis B vaccine-induced responses after
short-term travel from temperate regions
(e.g., Montreal) to the tropics for beach hol-
idays versus other types of low-UVR expo-
sure travel is also feasible. Drs. Duncan and
Regan described personal dosimeters, poly-
sulphone badges (8), and badges consisting
of dried Lambda DNA between layers of
ACLAR film (9, respectively, which could
be used along with radiometric measures of
Table 1. UVR dose in millijoules (mJ/cm2) required to suppress immune responses by 50%: compilation of
dose-response data presented by different investigators
Response Mouse Human Rat
UVsensitivity ED50 Skin type ED50 ED50
Contactsensitivity High (C57BL/6) 220a Fair gob
Intermediate 600a Medium 140b
(C3H/HeN)
Low(BALB/c) 1,230a Dark 150b
DTH to MLM BALB/c 230C - - _
DTH to BCG BALB/c 270C - - _
Mixed-skin lymphocyte response - - Mixed 418d 108d
Lymphocyte proliferation to bacteria - - - -680d
Abbreviations: ED50,dose causing 50% suppression of immune response; DTH, delayed-type hypersensitivity;
MLM, Mycobacteriium lepraemuriunr, BCG, Mycobacterium bovis.
aData from Noonan and Hoffman (3).
bData from Oberhelman et al. (4) and Assaf(unpublished data).
cData from Jeevan and Kripke (6).
dData from Van Loveren et al.(7).
ambient UVR to estimate exposure doses in
the studies described by Dr. Ward. Hence,
there appear to be opportunities to deter-
mine dose-response relationships for effects
ofUVR on the effectiveness ofcertain vacci-
nations.
Session 3: UWR modulation ofT-helper
(Th) lymphocyte subpopulations: potential
consequencesfor allergic and autoimmune
disease. Whereas most of the concern over
UVR modulation ofthe immune system has
focused on potential effects on susceptibility
to skin cancer and infectious disease, the
mechanisms by which UVR modifies
immune responses might also result in
increased risks associated with allergic and
autoimmune disease. Dr. Ullrich described
studies in mice that suggest that interleukin-
10, released from keratinocytes following
UVR exposure, circulates in the blood
stream, alters antigen presentation to Thl
cells but not Th2 cells, and results in the
suppression ofDTH (JO). Because ThI and
Th2 cells are mutually antagonistic, and
because Th2 cells are responsible for imme-
diate-type hypersensitivity to allergens such
as dust mites, UVR has the potential to
exacerbate allergic disease. Dr. Peden pre-
sented information suggesting that Th2 cells
have an important role in atopic asthma in
humans. Dr. McCauliffe presented informa-
tion on the effects ofUVR on autoimmune
disease, particularly systemic lupus erythe-
matosus (SLE). The pathogenesis of sys-
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Figure 1. Parallelogram model. Dose (mJ/cm2)
required to suppress contact hypersensitivity by
50% for BALB/c mice from Noonan (3) and
delayed-type hypersensitivity to Mycobacterium
bovis from Jeevan (6) are indicated in circles on
left. Data for suppression of contact sensitivity in
most resistant humans [K.D. Cooper, personal
communication (4)] is represented in upper right
corner. Data from vaccine effectiveness study
could be used in lower right corner. Factors could
then be obtained to describe the relationship
between these parameters and would indicate in
a quantitative fashion the ability of effects on con-
tact hypersensitivity to predict effects on immune
responses to infection and the ability of mouse
data to predict human effects.
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temic autoimmune disease such as SLE
appears to be mediated byTh2 cells, in con-
trast to organ-specific autoimmune diseases
(e.g., insulin-dependent diabetes mellitus),
where Th1 cells appear to be more impor-
tant. Hence, UVR has the potential to affect
autoimmune diseases in either an adverse or
beneficial fashion depending on the disease.
Summary ofresearch needs identified.
The group was unanimous in giving high-
est priority to studying the effects of UVR
on vaccine effectiveness in humans. All
three studies presented by Dr. Ward would
be valuable. However, the proposed studies
were ranked in priority as follows 1) BCG,
2) measles, and 3) hepatitis. There was
consensus that these studies should incor-
porate the use of both personal dosimeters
and radiometric measurements of ambient
UVR in order to obtain dose-response
information.
Information on the effects of UVR
should be expanded beyond DTH and CH.
Other types of immune functions, such as
epidermal mixed-lymphocyte reactions and
serum cytokine responses, should be
assessed in both rodents and humans. This
information is needed to characterize the
extent of damage to the immune system,
provide additional mechanistic information,
and provide insights about the types of
infections likely to be affected by UVR.
Suppression of CH responses has only
been demonstrated in humans following
application of the allergen to the site of
UVR exposure. Unlike the mouse model,
limited attempts to demonstrate effects with
application to a distant site have been
unsuccessful. However, suppression of the
lymphoproliferative response of peripheral
blood lymphocytes to herpes simplex virus
has been observed following UVR exposure
(11). Additional work is needed to deter-
mine the extent to which systemic suppres-
sion ofimmune responses occurs in humans
and underwhat experimental conditions.
More information is needed on the
wavelength dependency of UVR-induced
immune suppression. Although some ani-
mal studies have been done with narrow
bands of UVR, most studies have used
broad-spectrum SF 40 sunlamps. There is
little information on the action spectrum
for human immune suppression. Questions
requiring answers include: Is the action
spectrum for immune suppression the same
for mice and humans? What role does
UVA play in immune suppression and are
there potential interactions between UVA
and UVB? Are data generated with SF
lamps similar enough to solar exposure to
be useful in making quantitative risk assess-
ments with respect to depletion of stratos-
pheric ozone?
Finally, UVR appears to favor Th2
responses, suggesting that risks associated
with common allergies and asthma may be
increased by UVR exposure. This possibili-
ty has not been explored. Also, although
UVR is known to exacerbate certain
autoimmune diseases, the link with UVR-
modulation ofthe immune system has not
been made. The group felt that these risks
could best be addressed using animal mod-
els. Should these studies suggest that UVR
can enhance allergic or autoimmune dis-
ease, then human studies could be planned
to assess these risks.
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